Wages cover the bills. Dividends buy back your time. Earned income stops when you do; portfolio income deposits into your brokerage account on a fixed schedule set by a board of directors, not your employer.
Finding yield that beats the risk-free benchmark by a wide enough margin to justify equity risk matters in 2026. With the 10-year Treasury yielding 4.34%, dividend yields in the 6% to 10% range look genuinely interesting, especially from consumer staples and large-cap pharma names that have absorbed multi-year share-price declines. High-yield equities offer instant liquidity, zero tenant headaches, and the freedom to redeploy capital with a single click.
We screened our 24/7 Wall St. dividend equity research database and found a collection of companies that, combined, can generate over $1,188 a year in passive annual income if you invest $5,000 in each stock at the time of this writing.
Pfizer
- Stock #3: Pfizer (NYSE: PFE)
- Yield: 6.37%
- Shares for $5,000: 185
- Annual Passive Income: ~$318.20
Pfizer (NYSE: PFE | PFE Price Prediction) is a large-cap biopharma with franchises spanning Eliquis, Prevnar, Vyndaqel, Ibrance, Xtandi, Padcev, Comirnaty, and Paxlovid. The high yield reflects a depressed share price rather than a stretched payout: PFE has spent the past two years digesting its COVID revenue cliff and patent loss-of-exclusivity headwinds.
Management guided FY2026 revenue to $59.5 billion to $62.5 billion and adjusted EPS to $2.80 to $3.00, supported by a $7.2 billion targeted cost-savings program by the end of 2027. The current quarterly payout sits at $0.43 per share, or $1.72 annualized. Institutional ownership runs 67.8%, with Vanguard, BlackRock, and State Street as the largest holders.
Campbell’s
- Stock #2: Campbell’s (NASDAQ: CPB)
- Yield: 7.57%
- Shares for $5,000: 242
- Annual Passive Income: ~$377.52
Campbell’s (NASDAQ: CPB) owns Campbell’s, Rao’s, Goldfish, Pepperidge Farm, Snyder’s of Hanover, Cape Cod, Kettle Brand, Prego, Pace, V8, and SpaghettiOs across Meals & Beverages and Snacks. The yield is elevated because shares are down 40.56% over the past year, weighed down by a soft Snacks segment and a guidance cut to FY26 adjusted EPS of $2.15 to $2.25.
The current dividend stands at $0.39 per quarter, or $1.56 annualized, after a recent increase from $0.37. Rao’s has now surpassed $1 billion in trailing-twelve-month revenue, and Campbell’s agreed to acquire 49% of La Regina, the Italian producer of Rao’s, for $286 million. The buyback runway includes roughly $172 million anti-dilutive plus $301 million strategic authorization. Institutional ownership is 62.5%.
Conagra Brands
- Stock #1: Conagra Brands (NYSE: CAG)
- Yield: 9.88%
- Shares for $5,000: 352
- Annual Passive Income: ~$492.80
Conagra Brands (NYSE: CAG) sells Birds Eye, Duncan Hines, Healthy Choice, Marie Callender’s, Reddi-wip, Slim Jim, and Angie’s BOOMCHICKAPOP across Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. Shares trade near a 52-week low of $14.04 following a $968 million Q2 impairment, pushing the yield close to double digits.
The quarterly dividend has held at $0.35 per share since Q1 2023, equating to $1.40 annualized. Management narrowed FY26 adjusted EPS guidance to roughly $1.70, guided free-cash-flow conversion to about 105%, and reduced net debt by $818 million year over year. Institutions hold 87.2% of the float, led by Vanguard, BlackRock, and State Street.
Putting It All Together
Combined, these 3 positions generate $1,188.52 in annual passive income on a $15,000 investment, a blended yield of 7.92%. Conagra contributes $492.80, Campbell’s adds $377.52, and Pfizer rounds out the portfolio with $318.20.
| Ticker | Investment | Yield | Annual Income | Share of Total |
|---|---|---|---|---|
| CAG | $5,000 | 9.88% | $492.80 | 41.5% |
| CPB | $5,000 | 7.57% | $377.52 | 31.8% |
| PFE | $5,000 | 6.37% | $318.20 | 26.8% |
| Total | $15,000 | 7.92% | $1,188.52 | 100% |
Reinvesting these payouts compounds the position size every quarter without new capital, and the underlying businesses (frozen meals, soup, snacks, prescription medicines) generate cash through every phase of the economic cycle. That combination of recession-resistant demand and quarterly cash distributions makes high-yield equities a durable building block in any income-focused portfolio.
Top Gaining Stocks
Top Losing Stocks